Nuveen Asset Management, LLC Oramed Pharmaceuticals Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $575,591 - $1.39 Million	-154,729 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $32,031 - $54,323	-3,911 Reduced 2.47%	154,729 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $867,829 - $1.99 Million	66,859 Added 72.85%	158,640 $2.27 Million
Q3 2021 Nov 12, 2021	SELL	$12.13 - $23.82 $1,940 - $3,811	-160 Reduced 0.17%	91,781 $1.88 Million
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $766,787 - $1.34 Million	91,941 New	91,941 $1.23 Million

6.37M

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.